MedPath

Treatment with aflibercept for AMD cases with better value in optometry

Not Applicable
Recruiting
Conditions
age-related macular degeneration
Registration Number
JPRN-UMIN000012221
Lead Sponsor
Keio University, School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)Prior treatment with triamcinolone (<3 montsh 2)Prior treatment with dexamethasone <30 days) 3)Prior intraocular surgery (<3 months) 4)Prior vitrectomy 5)Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 6)Patient with pregnancy or its possibility, and with breast-feeding 7)Patient who the doctor in charge judges are ineligible for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with less exudative changes on optical coherence tomography(OCT) at month 6
Secondary Outcome Measures
NameTimeMethod
Results of visual acuity, OCT, angiography, and QOL research
© Copyright 2025. All Rights Reserved by MedPath